Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Oberbauer

Showing results (91-100 of 291) with videos related to

Pageof 30
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 29, 2004
The effect of ACE inhibitor and angiotensin II blocker therapy on early posttransplant kidney graft functionMatthias Lorenz, Elke Billensteiner, Martin Bodingbauer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 1, 2008
ACE-inhibitor or AT2-antagonist therapy of renal transplant recipients is associated with an increase in serum potassium concentrationsChrista Mitterbauer, Georg Heinze, Alexander Kainz, et al.
NDT Plus|May 8, 2015
Biocompatibility of peritoneal dialysis solutions determined by genomics of human leucocytes: a cross-over studyJulia Wilflingseder, Paul Perco, Alexander Kainz, et al.
Frontiers in Physiology|May 17, 2021
Aldosterone Is Positively Associated With Circulating FGF23 Levels in Chronic Kidney Disease Across Four Species, and May Drive FGF23 Secretion DirectlyJudith Radloff, Maximilian Pagitz, Olena Andrukhova, et al.
American Journal of Physiology. Renal Physiology|June 13, 2002
Effects of microinjection of synthetic Bcl-2 domain peptides on apoptosis of renal tubular epithelial cellsElisabeth Peherstorfer, Bernd Mayer, Stefan Boehm, et al.
Omics : a Journal of Integrative Biology|March 10, 2012
Molecular pathways and crosstalk characterizing the cardiorenal syndromeIrmgard Mühlberger, Konrad Mönks, Raul Fechete, et al.
Transplantation Reviews (Orlando, Fla.)|January 21, 2020
Optimization of tacrolimus in kidney transplantation: New pharmacokinetic perspectivesRainer Oberbauer, Oriol Bestard, Lucrezia Furian, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 26, 2015
Molecular disease presentation in diabetic nephropathyAndreas Heinzel, Irmgard Mühlberger, Gil Stelzer, et al.
BMC Medicine|January 13, 2017
Steroid withdrawal after renal transplantation: a retrospective cohort studyMaria C Haller, Michael Kammer, Alexander Kainz, et al.
Frontiers in Immunology|July 23, 2021
Renal Delivery of Pharmacologic Agents During Machine Perfusion to Prevent Ischaemia-Reperfusion Injury: From Murine Model to Clinical TrialsRossana Franzin, Alessandra Stasi, Marco Fiorentino, et al.
Pageof 30

Showing results (91-100 of 291) with videos related to

Sort By:
Pageof 30
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 29, 2004
The effect of ACE inhibitor and angiotensin II blocker therapy on early posttransplant kidney graft functionMatthias Lorenz, Elke Billensteiner, Martin Bodingbauer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 1, 2008
ACE-inhibitor or AT2-antagonist therapy of renal transplant recipients is associated with an increase in serum potassium concentrationsChrista Mitterbauer, Georg Heinze, Alexander Kainz, et al.
NDT Plus|May 8, 2015
Biocompatibility of peritoneal dialysis solutions determined by genomics of human leucocytes: a cross-over studyJulia Wilflingseder, Paul Perco, Alexander Kainz, et al.
Frontiers in Physiology|May 17, 2021
Aldosterone Is Positively Associated With Circulating FGF23 Levels in Chronic Kidney Disease Across Four Species, and May Drive FGF23 Secretion DirectlyJudith Radloff, Maximilian Pagitz, Olena Andrukhova, et al.
American Journal of Physiology. Renal Physiology|June 13, 2002
Effects of microinjection of synthetic Bcl-2 domain peptides on apoptosis of renal tubular epithelial cellsElisabeth Peherstorfer, Bernd Mayer, Stefan Boehm, et al.
Omics : a Journal of Integrative Biology|March 10, 2012
Molecular pathways and crosstalk characterizing the cardiorenal syndromeIrmgard Mühlberger, Konrad Mönks, Raul Fechete, et al.
Transplantation Reviews (Orlando, Fla.)|January 21, 2020
Optimization of tacrolimus in kidney transplantation: New pharmacokinetic perspectivesRainer Oberbauer, Oriol Bestard, Lucrezia Furian, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 26, 2015
Molecular disease presentation in diabetic nephropathyAndreas Heinzel, Irmgard Mühlberger, Gil Stelzer, et al.
BMC Medicine|January 13, 2017
Steroid withdrawal after renal transplantation: a retrospective cohort studyMaria C Haller, Michael Kammer, Alexander Kainz, et al.
Frontiers in Immunology|July 23, 2021
Renal Delivery of Pharmacologic Agents During Machine Perfusion to Prevent Ischaemia-Reperfusion Injury: From Murine Model to Clinical TrialsRossana Franzin, Alessandra Stasi, Marco Fiorentino, et al.
Pageof 30